Quercus infectoria Oliv.

Pharmaceutical Biology

Volumn 46, Issue 6, 2008, Pages 367-372

  Voravuthikunchai, Supayang Piyawan ^a   Chusri, Sasitorn ^a   Suwalak, Sakol ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Escherichia coli O157: H7; Helicobacter pylori; Methicillin resistant Staphylococcus aureus; Multi drug resistant Klebsiella pneumoniae; Quercus infectoria; Salmonella

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; CHLORAMPHENICOL; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; OXACILLIN; PLANT EXTRACT; QUERCUS INFECTORIA EXTRACT; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; AQUEOUS SOLUTION; ARTICLE; BACILLUS CEREUS; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTER FAECALIS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HELICOBACTER PYLORI; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUERCUS INFECTORIA; SALMONELLA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; SALMONELLA WELTEVREDEN; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PYOGENES;

ACINETOBACTER BAUMANNII; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; FAGACEAE; HELICOBACTER PYLORI; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; QUERCUS INFECTORIA; SALMONELLA; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PYOGENES;

EID: 45849104278     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802055784     Document Type: Article

References (29)

1. Berns JS (2003): Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dialysis 16: 30-37.
2. Bower JR (1999): Foodborne diseases: Shiga toxin producing E. coli (STEC). Pediatr J Infect Dis 18: 909-910.
3. Cowan MM (1999): Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
4. Dixon MF (1997): Role of Helicobacter pylori on gastric mucosal damage, gastric cancer, and gastric malt lymphomacommentary. Gastroenterology 113 (Suppl. 6): 65-66.
5. Graham DY (1998): Antibiotic resistance in Helicobacter pylori: Implications for therapy. Gastroenterology 115: 1272-1277.
6. Griffin PM, Tauxe RV (1991): The epidemiology of infections caused by Escherichia coli O157: H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13: 60-98.
7. Grosvenor PW, Supriono A, and Gray DO (1995): Medicinal plants from Riau Province, Sumatra, Indonesia. Part 2: Antibacterial and antifungal activity. J Ethnopharmacol 45: 97-111.
8. Guan J, Chan M, Allain B, Mandeville R, Brooks BW (2006): Detection of multiple antibiotic-resistant Salmonella enterica serovar Typhimurium DT104 by phage replication-competitive enzyme-linked immunosorbent assay. J Food Prot 69: 739-742.
9. Kuipers EJ (1997): Helicobacter pylori and the risk and management of associated disease: Gastritis, ulcer disease, and gastric cancer. Aliment Pharmacol Ther 11 (Suppl. 1): 71-78.
10. Leclercq R (2002): Gram-positive cocci multiresistant to antibiotics: Activity of linezolid. Med Maladies Infect 32: 449-459.
11. Marshall BJ, Armstrong J (1995): Attempt to prove Koch's postulates for pylori campylobacter. Med J Aust 142: 436-439.
12. Martinez-Martinex L, Pascual A, Hernandez-Alles S, Alvarez-Diaz D, Suarez AI, Tran J, Benedi VJ, Jacoby GA (1999): Role of β-lactamases and porins in activities of carbapenems and cephalospolins against Klebsiella pneumoniae. Antimicrob Agent Chemother 43: 1669-1673.
13. McCutcheon AR, Ellis SM, Hancock REW, Towers GHN (1992): Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol 37: 213-223.
14. Megraud F (1997): Resistance of Helicobacter pylori infection to antibiotic. Aliment Pharmacol Ther 11 (Suppl 1): 43-53.
15. Megraud F (2001): Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resistance Updates 4: 178-186.
16. Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV, Woods DE (1988): Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: A two-year prospective study. J Infect Dis 157: 1054-1057.
17. Paton JC, Paton AW (1998): Pathogenesis and diagnosis of shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11: 450-479.
18. Riley LW (1987): The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Ann Rev Microbiol 41: 383-407.
19. Scotland SM, Rowe B, Smith HR, Willshaw GA, Gross RJ (1988): Verocytotoxin-producing strains of Escherichia coli from children with HUS and their detection by specific DNA probes. J Med Microbiol 25: 237-243.
20. Tompkins DS, Perkin J, Smith C (1997): Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin. Helicobacter 2: 185.
21. Voravuthikunchai SP, Kitpipit L (2005): Effective medicinal plant extracts against hospital strains of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 11: 510-512.
22. Voravuthikunchai SP, Limsuwan S, Mitchell H (2006): Effects of Punica granatum pericarps and Quercus infectoria nutgalls on cell surface hydrophobicity and cell survival of Helicobacter pylori. J Health Sci 52: 154-159.
23. Voravuthikunchai SP, Lortheeranuwat A, Ninrprom T, Popaya W, Pongpaichit S, Supawita T (2004): Effective medicinal plants against enterohaemorrhagic Escherichia coli O157: H7. J Ethnopharmacol 94: 49-54.
24. Ward PB, Joheson PDR, Grabsch EA, Mayall BC, Grayson ML (2001): Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 175: 480-483.
25. Wells T, Barrett J, Griffin PM (1995): A university outbreak of Escherichia coli O157: H7 infections associated with roast beef and an unusually benign clinical course. J Infect Dis 172: 1122-1125.
26. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MF, Isaacson PG (1993): Helicobacter pylori-associated gastritis and primary B-cell lymphoma. Lancet 338: 1175-1176.
27. Yoh M, Frimpong EK, Honda T (1997): Effect of antimicrobial agents, especially fosfomycin on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157: H7. FEM Immun Medical Microbiol 19: 57-64.
28. Yoh M, Frimpong EK, Voravuthikunchai S, Honda T (1999): Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157: H7. Can J Microbiol 45: 732-739.
29. Wiart C, Kumar A (2001): Practical Handbook of Pharmacognosy. Selangor, Malaysia, Pearson Education Malaysia Sdn Bhd., p. 24.